These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23047169)

  • 1. Mucous membrane pemphigoid: recent advances.
    Srikumaran D; Akpek EK
    Curr Opin Ophthalmol; 2012 Nov; 23(6):523-7. PubMed ID: 23047169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic and therapeutic recommendations for mucous membrane pemphigoid of the eye].
    Heiligenhaus A; Bonsmann G; Heinz C; Schneider S; Zierhut M; Behrens-Baumann W
    Klin Monbl Augenheilkd; 2005 Sep; 222(9):689-703. PubMed ID: 16175478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular mucous membrane pemphigoid: a review.
    Taurone S; Spoletini M; Ralli M; Gobbi P; Artico M; Imre L; Czakò C; Kovàcs I; Greco A; Micera A
    Immunol Res; 2019 Jun; 67(2-3):280-289. PubMed ID: 31327149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Use of Rituximab and Intravenous Immunoglobulin for Severe Autoimmune Cicatricial Conjunctivitis-An Interventional Case Series.
    Steger B; Madhusudan S; Kaye SB; Stylianides A; Romano V; Maqsood SE; Harper J; Ahmad S
    Cornea; 2016 Dec; 35(12):1611-1614. PubMed ID: 27661067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug induced cicatrizing conjunctivitis: A case series with review of etiopathogenesis, diagnosis and management.
    Singh S; Donthineni PR; Shanbhag SS; Senthil S; Ong HS; Dart JK; Basu S
    Ocul Surf; 2022 Apr; 24():83-92. PubMed ID: 35247582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucous membrane pemphigoid and pseudopemphigoid.
    Thorne JE; Anhalt GJ; Jabs DA
    Ophthalmology; 2004 Jan; 111(1):45-52. PubMed ID: 14711713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of mucous membrane pemphigoid: a literature review and update.
    Alrashdan MS; Kamaguchi M
    Eur J Dermatol; 2022 May; 32(3):312-321. PubMed ID: 36065531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Progressive Cicatrizing Conjunctivitis With Negative Immunofluorescence Staining.
    You JY; Eberhart CG; Karakus S; Akpek EK
    Am J Ophthalmol; 2020 Jan; 209():3-9. PubMed ID: 31560878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification to the approach of the diagnosis of mucous membrane pemphigoid: A case report and literature review.
    Parisi E; Raghavendra S; Werth VP; Sollecito TP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Feb; 95(2):182-6. PubMed ID: 12582358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics Upon Presentation of Ocular Mucous Membrane Pemphigoid Patients in Puerto Rico.
    Méndez-Bermúdez IJ; Maldonado-Cerda A; Marrero-Barrera F; Oliver-Cruz AL
    P R Health Sci J; 2020 Mar; 39(1):34-38. PubMed ID: 32383565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
    Shetty S; Ahmed AR
    J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I
    Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].
    Meyer-ter-Vehn T; Schmidt E; Zillikens D; Geerling G
    Ophthalmologe; 2008 Apr; 105(4):405-19. PubMed ID: 18392628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.
    Dart JK
    Eye (Lond); 2017 Feb; 31(2):301-332. PubMed ID: 28106896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to do conjunctival and buccal biopsies to investigate cicatrising conjunctivitis: improving the diagnosis of ocular mucous membrane pemphigoid.
    Grau AE; Setterfield J; Saw VP
    Br J Ophthalmol; 2013 Apr; 97(4):530-1. PubMed ID: 23335207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucous Membrane Pemphigoid with Ocular Involvement: The Clinical Phenotype and Its Relationship to Direct Immunofluorescence Findings.
    Ong HS; Setterfield JF; Minassian DC; Dart JK;
    Ophthalmology; 2018 Apr; 125(4):496-504. PubMed ID: 29217149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of ocular disease in mucous membrane pemphigoid.
    Brunner M; Lacoste KJ; Bernauer W
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):331-4. PubMed ID: 24771161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laryngeal mucous membrane pemphigoid serves as a prognostic factor for poor response to treatment with rituximab.
    Baniel A; Oestreicher-Kedem Y; Peled A; Bar-Ilan E; Geller S; Sprecher E; Baum S
    Clin Exp Dermatol; 2021 Jul; 46(5):915-919. PubMed ID: 33811681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.